Innoviva (INVA) 10-K 2019 FY Annual report

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:

(1)          Registration Statement on Form S‑8 No 333‑119559 of Theravance, Inc. pertaining to the 2004 Equity Incentive Plan and the 2004 Employee Stock Purchase Plan,

(2)          Registration Statement on Form S‑8 No 333‑129669 of Theravance, Inc. pertaining to the 2004 Employee Stock Purchase Plan,

(3)          Registration Statement on Form S‑8 No 333‑142707 of Theravance, Inc. pertaining to the 2004 Equity Incentive Plan,

(4)          Registration Statement on Form S‑8 No 333‑150753 of Theravance, Inc. pertaining to the 2008 New Employee Equity Incentive Plan and the 2004 Employee Stock Purchase Plan,

(5)          Registration Statement on Form S‑8 No 333‑159042 of Theravance, Inc. pertaining to the 2004 Employee Stock Purchase Plan,

(6)          Registration Statement on Form S‑8 No 333‑166546 of Theravance, Inc. pertaining to the 2004 Equity Incentive Plan,

(7)          Registration Statement on Form S‑8 No 333‑173923 of Theravance, Inc. pertaining to the 2004 Employee Stock Purchase Plan,

(8)          Registration Statement on Form S‑8 No 333‑181763 of Theravance, Inc. pertaining to the 2012 Equity Incentive Plan, and

(9)          Registration Statement on Form S‑8 No 333‑197950 of Theravance, Inc. pertaining to the 2012 Equity Incentive Plan, the Amended and Restated 2008 New Employee Equity Incentive Plan, the 2004 Equity Incentive Plan and the 1997 Stock Plan

of our report dated February 19, 2019, with respect to the consolidated financial statements of Innoviva, Inc. as of December 31, 2018 and for the years ended December 31, 2018 and 2017, included in this Annual Report (Form 10‑K) of Innoviva, Inc. for the year ended December 31, 2019.

/s/ Ernst & Young LLP

San Jose, California

February 18, 2020